Markets › United States › NAS › XGN

Exagen Inc

NAS:XGNHealthcareNASDAQ:NCXnasdaq_composite

$7.43−3.76%At closeAt close · Tue 20 Oct · ≈ AED 27.29 · Market cap $179.99M · Next earnings Tue 3 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	60.6%	57.4%	46.9%	56.1%	59.5%	58.3%	—	—
Operating margin	−36.2%	−49.8%	−101.1%	−43.5%	−24.5%	−21.1%	−21.1%	+0.0 pts
Net margin	−39.8%	−55.6%	−104.0%	−45.1%	−27.2%	−30.0%	−30.0%	+0.0 pts
EBITDA margin	−32.5%	−47.8%	−95.8%	−36.4%	−20.0%	−20.2%	—	—
Return on equity	−39.9%	−31.6%	−111.6%	−104.4%	−158.4%	−114.3%	−114.3%	+0.0 pts
Return on assets	−21.3%	−21.8%	−55.0%	−41.6%	−33.8%	−34.4%	−34.4%	+0.0 pts
Return on capital employed	−21.8%	−21.1%	−60.1%	−50.7%	−43.7%	−32.1%	—	—
Debt / equity	0.6×	0.3×	0.8×	1.0×	2.4×	1.5×	1.5×	+0.0%
Debt / assets	34.4%	22.7%	40.8%	40.8%	51.9%	44.3%	—	—
Interest coverage	−5.9×	−9.2×	−18.8×	−9.8×	−6.1×	−3.3×	—	—
Current ratio	8.0×	12.1×	7.5×	4.0×	2.7×	3.5×	3.5×	+0.0%
Quick ratio	8.0×	12.1×	7.5×	4.0×	2.7×	3.5×	—	—
Cash ratio	6.5×	10.7×	6.5×	3.1×	1.6×	2.3×	2.3×	+0.0%
Asset turnover	0.5×	0.4×	0.5×	0.9×	1.2×	1.1×	—	—
Receivables turnover	4.7×	5.0×	7.5×	8.0×	7.1×	6.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—